Polypoidal choroidal vasculopathy: An update on current management and review of literature
- PMID: 31198666
- PMCID: PMC6557071
- DOI: 10.4103/tjo.tjo_35_18
Polypoidal choroidal vasculopathy: An update on current management and review of literature
Abstract
Polypoidal choroidal vasculopathy (PCV) is a subtype of neovascular age-related macular degeneration (nAMD), commonly seen in the Asian population. It is dissimilar in epidemiology, genetic heterogeneity, pathogenesis, natural history, and response to treatment in comparison to nAMD. Confocal scanning laser ophthalmoscopy-based simultaneous fluorescein angiography and indocyanine green angiography, spectral-domain optical coherence tomography (OCT) with enhanced depth imaging, swept-source OCT, and OCT angiography have improved the ability to detect PCV, understand its pathology, and monitor treatment response. A plethora of literature has discussed the efficacy of photodynamic therapy, anti-vascular endothelial growth factor (VEGF) monotherapy, and combination of both, but only a few studies with higher level of evidence and limited follow-up duration are available. This review discusses the understanding of PCV with respect to epidemiology, pathogenesis, clinical features, natural history, imaging techniques, and various treatment options. Recent clinical trials (EVEREST-II and PLANET study) have emphasized that either anti-VEGF monotherapy or combination treatment is equally capable to strike a balance between polyp regression and stabilization of visual acuity. The recurrent nature of the disease, the development of macular atrophy, and the long-term poor visual prognosis despite treatment are concerns that open avenues for further research.
Keywords: Epidemiology; imaging; natural history; pathogenesis; polypoidal choroidal vasculopathy; treatment.
Conflict of interest statement
The authors declare that there are no conflicts of interests of this paper.
Figures



Similar articles
-
Current management strategy of polypoidal choroidal vasculopathy.Indian J Ophthalmol. 2018 Dec;66(12):1727-1735. doi: 10.4103/ijo.IJO_975_18. Indian J Ophthalmol. 2018. PMID: 30451173 Free PMC article. Review.
-
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.Ophthalmology. 2018 May;125(5):708-724. doi: 10.1016/j.ophtha.2017.11.019. Epub 2018 Jan 10. Ophthalmology. 2018. PMID: 29331556 Review.
-
IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.Retina. 2019 Sep;39(9):1655-1663. doi: 10.1097/IAE.0000000000002228. Retina. 2019. PMID: 29927796
-
Photodynamic therapy for polypoidal choroidal vasculopathy.Prog Retin Eye Res. 2013 Nov;37:182-99. doi: 10.1016/j.preteyeres.2013.09.003. Epub 2013 Oct 15. Prog Retin Eye Res. 2013. PMID: 24140257 Review.
-
[Polypoidal choroidal vasculopathy].Nippon Ganka Gakkai Zasshi. 2012 Mar;116(3):200-31; discussion 232. doi: 10.4264/numa.71.282. Nippon Ganka Gakkai Zasshi. 2012. PMID: 22568102 Review. Japanese.
Cited by
-
Association of HERPUD1 genetic variant rs2217332 with age-related macular degeneration and polypoidal choroidal vasculopathy in an Indian cohort.Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):1205-1212. doi: 10.1007/s00417-022-05861-w. Epub 2022 Oct 12. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36220983
-
Differences between young and elderly polypoidal choroidal vasculopathy patients with and without pachychoroid phenotypes.Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1765-1776. doi: 10.1007/s00417-023-06361-1. Epub 2024 Jan 17. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38231247
-
Fractal analysis of polypoidal choroidal neovascularisation in age-related macular degeneration.Br J Ophthalmol. 2021 Oct;105(10):1421-1426. doi: 10.1136/bjophthalmol-2020-317011. Epub 2020 Sep 5. Br J Ophthalmol. 2021. PMID: 32892164 Free PMC article.
-
Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study.Sci Rep. 2021 Jan 11;11(1):470. doi: 10.1038/s41598-020-80731-1. Sci Rep. 2021. PMID: 33432090 Free PMC article.
-
Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy.BMC Ophthalmol. 2019 Nov 16;19(1):229. doi: 10.1186/s12886-019-1244-5. BMC Ophthalmol. 2019. PMID: 31733642 Free PMC article.
References
-
- Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina. 1990;10:1–8. - PubMed
-
- Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina. 1995;15:100–10. - PubMed
-
- Laude A, Cackett PD, Vithana EN, Yeo IY, Wong D, Koh AH, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: Same or different disease? Prog Retin Eye Res. 2010;29:19–29. - PubMed
-
- Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH. Photodynamic therapy for polypoidal choroidal vasculopathy. Prog Retin Eye Res. 2013;37:182–99. - PubMed
-
- Stanga PE, Lim JI, Hamilton P. Indocyanine green angiography in chorioretinal diseases: Indications and interpretation: An evidence-based update. Ophthalmology. 2003;110:15–21. - PubMed